尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Violin Jonathan, 董事. Director active across 2 companies, notably Astria Therapeutics, Inc.. In total, 10 disclosures have been logged. Split: 0 buy · 6 sells. Total volume traded: €3.4m. History available since 20 September 2021. The latest transaction was filed on 2 February 2023 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Violin Jonathan is Président et Administrateur. He is linked to Viridian Therapeutics, Inc.\DE, where he is Chief Executive Officer, and to Astria Therapeutics, Inc., where he is Director. Across the 10 filings recorded, the 10 observed filings between 2021-09-22 and 2026-01-23 are all sales, with sum_sell_eur of 3429479 and sum_buy_eur of 0.